Perrigo Co Plc (Perrigo) is a manufacturer and distributor of consumer self-care products, over-the-counter health, and wellness solutions. Perrigo operates primarily in the self-care industry, offering a wide range of products across various categories, including upper respiratory, nutrition, digestive health, pain and sleep-aids, oral care, healthy lifestyle, skin care, women's health, vitamins, minerals, supplements, rare diseases business, and other miscellaneous self-care products. The company serves markets in North America, Europe, and Asia. Products include cough suppressants, expectorants, sinus and allergy relief drugs, infant formulas, nutritional beverages, antacids, anti-diarrheal and anti-heartburn drugs, pain relievers, fever reducers, sleep aids, toothbrushes, toothbrush replacement heads, dental flossers, whitening products, toothbrush covers, smoking cessation and well-being products, dermatological care, scar management, lice treatment, other products for various skin conditions, feminine hygiene and contraceptives, vitamins, minerals, supplements, and other miscellaneous self-care products.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Perrigo has undertaken research and development (R&D) initiatives focused on developing and introducing high-quality solutions with differentiated product features and benefits. The company is involved in product reformulations, new brand development, brand line extensions, and the creation of differentiated products. The company invests in innovation, particularly in the Nutrition, Skin Care, and Women's Health categories, to strengthen its product portfolio and position itself for future growth. The R&D units of the company are responsible for managing its R&D activities, including innovation and regulatory capabilities to develop and launch new products and technologies. In FY2024, the company spent US$112.2 million on R&D, which as a percentage of revenue, stood at 2.6% and declined 8.4% YoY.